longbridge

Mesoblast

MESO
----

All Shareholders

Shareholder Type

  • Public and others37.86%
  • Individuals & Insiders34.17%
  • Institutions26.10%
  • Private companies1.08%
  • Public companies0.79%

Major Shareholders

Major Shareholders Latest
Shareholder
Gregory GeorgeNon-Independent Non-Executive Director
20.95%272.00M0.03%+0
Silviu ItescuFounder, CEO, MD, Chairman of Scientific Advisory Board & Executive Director
6.23%80.84M0.14%+1.89M
State Street Investment Management
5.16%67.00M<0.01%-18.25K
William Gueck
4.80%62.38M<0.01%+0
JPMorgan Chase & Co.
4.65%60.43M0.65%-8.37M
M&G Investment Management Limited
2.73%35.45M<0.01%+0
Vanguard Capital Management, LLC
2.47%32.13M0.01%-118.59K
BlackRock, Inc.
1.86%24.14M<0.01%-54.99K
Vanguard Investments Australia Limited
1.57%20.40M0.02%-200.79K
Dimensional Fund Advisors LP
1.36%17.62M0.02%-270.23K
Thorney Investment Group Australia Pty. Ltd.
1.08%13.98M0.01%-135.15K
AustralianSuper Advice Pty Ltd
0.88%11.47M<0.01%+0
Norges Bank Investment Management
0.85%11.06M0.08%-1.01M
Smith & Nephew plc
0.79%10.23M<0.01%+0
Josaka Investments Pty Ltd.
0.68%8.82M<0.01%+0
James George
0.62%8.00M<0.01%+0
Morgan Stanley
0.55%7.15M0.16%+2.04M
BetaShares Capital Limited
0.53%6.93M<0.01%+60.40K
Eric RoseChief Medical Officer & Executive Director
0.52%6.75M0.05%-643.25K
Grant George
0.46%6.00M<0.01%+0
© 2026 Longbridge｜Terms of ServicePrivacy Policy